We are live on ! Find out more
CPV

Canaan Partners VIII Portfolio holdings

AUM $31M
1-Year Est. Return 45.38%
This Fund
S&P 500
This Quarter Est. Return
+0.14%
1 Year Est. Return
-45.38%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$56.3M
AUM Growth
-$24.8M
Cap. Flow
-$11.6M
Cap. Flow %
-20.68%
Top 10 Hldgs %
100%
Holding
2
New
Increased
1
Reduced
1
Closed

Top Buys

Rank Stock Value
1
LQDA icon
Liquidia Corp
LQDA
+$551K

Top Sells

Rank Stock Value
1
CDLX icon
Cardlytics
CDLX
+$12.2M

Sector Composition

Rank Sector Weight
1 Healthcare 52.48%
2 Communication Services 47.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LQDA icon
1
Liquidia Corp
LQDA
$7.48B
$29.6M 52.48%
2,597,681
+34,378
+1% +$551K
CDLX icon
2
Cardlytics
CDLX
$21.7M
$26.8M 47.52%
161,814
-75,000
-32% -$12.2M

Similar funds

Canaan Partners VIII's Q1 2019 Portfolio in Review

As of Q1 2019, Canaan Partners VIII held 2 positions worth $56.3M, down 31% from $81.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Canaan Partners VIII withdrew a net $11.6M in Q1 2019, reducing 1 holding. Its largest reduction was Cardlytics, cutting an estimated $12.2M.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, down from 68% a quarter earlier, followed by Communication Services.

Against the trend, Canaan Partners VIII added an estimated $551K to Liquidia Corp.

  • Canaan Partners VIII added most to Liquidia Corp in Q1 2019, an estimated $551K increase.
  • Canaan Partners VIII's biggest Q1 2019 reduction was Cardlytics, cutting an estimated $12.2M.
  • Canaan Partners VIII's ten largest holdings make up 100% of its $56.3M portfolio in Q1 2019.
  • Canaan Partners VIII opened 0 new positions and closed 0 in Q1 2019.
  • Canaan Partners VIII's portfolio value fell 31% quarter-over-quarter to $56.3M.

Based on Canaan Partners VIII's 13F filing for Q1 2019, filed 9 May 2019.